Skip Navigation
High Contrast Mode
Off
On
Home
Search
Type a name or keyword
Search
Services
People
Careers
Attorneys
Students
Paralegals
Staff
Patent Agents
Firm
About Us
Locations
Events
Blogs
Publications
News
Eleanor Vaida Gerhards
Partner
egerhards@foxrothschild.com
Philadelphia, PA
Tel: 215.918.3642
Fax: 215.299.2150
Blue Bell, PA
Tel: 215.918.3642
Fax: 610.397.0450
Biography
Franchise, Licensing & Distribution Matters
Transactional
Conversion and Regulatory Matters
Startups and Emerging Growth Companies
International
Distribution
Corporate and Transactional Matters
Leadership
Women's Franchise Network
Honors & Awards
Publications
News
Events
events
Trademark and Internet Brand and Reputation Protection
When:
May 07, 2018
at 1:45pm
– 3:00pm
Hosted By:
IFA Legal Symposium
People:
Eleanor Vaida Gerhards
Location:
JW Marriott
Share on:
Associated Services
Franchising & Distribution
Biography
Franchise, Licensing & Distribution Matters
Transactional
Conversion and Regulatory Matters
Startups and Emerging Growth Companies
International
Distribution
Corporate and Transactional Matters
Leadership
Women's Franchise Network
Honors & Awards
Publications
News
Events
Firm Highlights
Slide 1 of 10
News
Los Angeles Medical Examiner Pushes for Greater Transparency in High-Profile Deaths
Read
More
Publication
The Presumption of Innocence Podcast Series
Read
More
News
Billboard’s 2026 Top Music Lawyers Revealed
Read
More
Publication
New Law Gives South Carolina Landlords Powerful Tools Against Squatters
Read
More
News
What Happens if I Claim Tax Relief Incorrectly? Here's What to Do Now
Read
More
News
Fox Rothschild Attorneys Featured on Billboard’s 2026 Top Music Lawyers List
Read
More
Publication
'Coordination Is Not Diligence': DNJ Reinforces Strict Standard for Amending Invalidity Contentions
Read
More
Publication
Navigating New Jersey’s CREAMMA: What Employers Need to Know
Read
More
News
Fox Rothschild’s Atlantic City Office Makes Waves for Cancer Support Community New Jersey at Gilda’s Club
Read
More
Publication
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
Read
More
Prev
Next